Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Kalydeco“
Suchtreffer
Begriffe & Kennungen
Kalydeco · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenKalydeco · 4.6 Fertility, pregnancy and lactation · 2
Eintrag öffnenKalydeco · 4.8 Undesirable effects · 1
Eintrag öffnenKalydeco · 4.8 Undesirable effects · 2
Eintrag öffnenKalydeco · 4.8 · 13 System organ class Adverse reactions Frequency Tinnitus common Tympanic membrane hyperaemia common Vestibul
Eintrag öffnenKalydeco · 4.8 · 14 placebo-treated patients, respectively. Two patients, one on placebo and one on ivacaftor permanently disco
Eintrag öffnenKalydeco · 4.8 · 15 Paediatric population
Eintrag öffnenKalydeco · 4.8 · 16 Ivacaftor in a combination regimen with ivacaftor/tezacaftor/elexacaftor
Eintrag öffnenKalydeco · 4.8 · 43 System organ class Adverse reactions Frequency Abnormal breathing* common Rhinorrhoea* common Sinus congest
Eintrag öffnenKalydeco · 4.8 · 44 was interrupted in most patients with transaminase elevations > 5 × ULN. In all instances where dosing was
Eintrag öffnenKalydeco · 4.8 · 45 6 years of age, 61 patients between 6 to less than 12 years of age and 94 patients between 12 to less than
Eintrag öffnenKalydeco · 4.8 · 46 During study 445-106 in patients aged 6 to less than 12 years, the incidence of maximum transaminase (ALT o
Eintrag öffnenKalydeco · 4.8 · Description of selected adverse reactions
Eintrag öffnenKalydeco · 4.8 · Description of selected adverse reactions
Eintrag öffnenKalydeco · 4.8 · During study 445-106 in patients aged 6 to less than 12 years, the incidence of maximum transaminase (ALT or A
Eintrag öffnenKalydeco · 4.8 · During study 445-111 in patients aged 2 to less than 6 years, 15 (20.0%) subjects had at least 1 rash event, 4
Eintrag öffnenKalydeco · 4.8 · During study 445-111 in patients aged 2 to less than 6 years, 15 (20.0%) subjects had at least 1 rash event, 4
Eintrag öffnenKalydeco · 4.8 · During study 445-111 in patients aged 2 to less than 6 years, the incidence of maximum transaminase (ALT or AS
Eintrag öffnenKalydeco · 4.8 · During study 445-111 in patients aged 2 to less than 6 years, the incidence of maximum transaminase (ALT or AS
Eintrag öffnenKalydeco · 4.8 · During the 24-week, open-label phase 3 study in patients aged 6 to less than 12 years (study 661-113 part B, n
Eintrag öffnen